Boehringer Ingelheim received the award for the successful implementation of transparency, flexibility and innovative aseptic technologies in this state-of-the-art product manufacturing area. The U-shape line design provides flexible usage of individual processing steps while maximising operational time of the area and allowing fast response to customer needs.
The newly added drug product area provides best practice for aseptic processing in isolator technology. It delivers all dosage forms essential for the parenteral application of biopharmaceuticals, for example double chamber cartridges, for which there is a growing demand in immunology indications.
The Biberach site is the home of Europe’s largest facilities dedicated to biopharmaceutical development and manufacturing and delivers services both for Boehringer Ingelheim’s own biopharmaceuticals business and for its biopharmaceutical contract manufacturing business, Boehringer Ingelheim BioXcellence™. The site provides the entire value chain from cell line and process development to commercial scale cell culture manufacturing and finally to the aseptic production of various dosage forms of finished drug product. Embedded in the global biopharmaceutical manufacturing network of Boehringer Ingelheim, the Fill & Finish unit provides dosage forms like liquid or lyophilized vials, prefilled syringes, single and dual-chamber cartridges using modern aseptic technologies.
About ISPE®
The Facility of the Year Award is an annual program recognising state-of-the-art pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance the delivery of a superior project, as well as reduce the cost of producing high-quality medicines sponsored by ISPE® (International Society for Pharmaceutical Engineering). www.facilityoftheyear.org/foya-winners-2014